Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects.
Saverio TremamunnoLinda TartaglioneAlessandro TelescaAlessandro RizziTamara FeliciFrancesco MazzottaAntonio De VitaEmanuele RizzoNello CambiseAntonietta BelmustoDario PitoccoGaetano Antonio LanzaPublished in: Endocrine (2024)
In this randomized small study we show that, in T2DM patients, CSII achieves a similar medium-term glycemic control compared to MDI, without any adverse effect on the cardiovascular system.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- end stage renal disease
- weight loss
- insulin resistance
- chronic kidney disease
- ejection fraction
- newly diagnosed
- open label
- physical activity
- preterm infants
- phase iii
- cardiovascular disease
- placebo controlled
- patient reported outcomes
- adipose tissue
- combination therapy
- clinical trial
- metabolic syndrome
- phase ii
- patient reported
- replacement therapy
- electronic health record